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http://dx.doi.org/10.1016/j.pedneo.2Congenital central hypoventilation syndrome (CCHS) is characterized by defective automatic
regulation of breathing, mostly during sleep. The diagnostic criteria of CCHS include persistent
sleep hypoventilation without primary cardiac, pulmonary disease or neuromuscular dysfunc-
tion, and no arousal response to hypoxemia and hypercapnia. Mutations in the PHOX2B gene
have been indentified in 93e100% of patients with CCHS. We report a CCHS case with presen-
tation of hypoventilation during sleep and Hirschsprung disease; moreover, a genetic study of
the patient confirmed the PHOX2B gene mutation as polyanaline stretch.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Congenital central hypoventilation syndrome (CCHS) is
a disorder characterized by failure of automatic control of
breathing, particularly during sleep.1,2 CCHS is a rare
disorder with an estimated prevalence of about one case forent of Pediatrics, Chi-Mei
wa Road, Yung Kang City,
ed.net.tw (M.-C. Lai).
an Pediatric Association. Publish
012.12.003every 200,000 live births.2 The essential clinical features
include (1) decreased ventilatory drive during sleep with
compromised central and peripheral chemoreflexes to
hypercarbia and hypoxemia, and (2) no recognizable brain,
neuromuscular, cardiopulmonary, or metabolic disorder
accounting for the ventilator defect.1,3 However, the clin-
ical manifestation varies from mild hypoventilation during
quiet sleep with adequate ventilation during wakefulness to
severe apnea during wakefulness.2,3 CCHS usually develops
in early infancy; however, in rare cases, patients remain
asymptomatic until an older age with a diagnosis of late-
onset CCHS.4 According to previous reports, patients withed by Elsevier Taiwan LLC. All rights reserved.
PHOX2B mutation in a CCHS newborn 69CCHS present varying degrees of autonomic dysfunction,4,5
and there is also a subset developing neurocristopathy and
tumors from neural crest origin.6 Recent studies have
identified an autosomal dominant inherited heterozygous
paired-like homeobox 2B (PHOX2B) gene de novo mutation
in at least 90% of CCHS cases.2,4,6 In this report, we describe
a male infant presenting typical hypoventilation with
genetic confirmation of PHOX2B polyanaline repeat.Figure 1 Genetic study showed a heterozygous mutation in
PHOX2B with the polyalanine stretch, as genotype of 20/27.
PC Z positive control; PHOX2B35 Z the affected patient;
WT Z wild type.2. Case Report
The patient was delivered via an uneventful elective
Cesarean section after a gestation of 38 weeks; head
circumference, body length, and birth weight were all
appropriate for gestational age. His mother received
regular prenatal examination, which showed no specific
finding except for polyhydramnios. The patient was hospi-
talized owing to occasional shallow breath with cyanosis
and slight hypotonia, but not floppy appearance; physical
examination showed mild abdominal distension, but
otherwise the patient was normal. He was treated with
antibiotics for suspected perinatal infection initially, and
nasal continuous positive airway pressure (NCPAP) was used
as respiratory support. However, his symptoms became
exacerbated despite NCPAP use, and mechanical ventila-
tion was needed for frequent apnea and desaturation. A
series of studies, including chest X-ray, echocardiogram,
brain sonogram, and electric encephalogram (EEG), was
conducted, but all showed no specific findings. Phenobar-
bital was initially prescribed for possible neonatal seizure,
but this was discontinued as seizure disorder was excluded
by clinical presentation and EEG finding. Because of the
improvement of his condition, mechanical ventilation was
shifted to NCPAP again; however, his apnea with desatu-
ration recurred. The symptoms occurred more often during
sleep, which was accompanied with diminished chest and
abdomen movements followed by hypoxemia and hyper-
capnia. He presented with normal muscle tone; the results
of screening for metabolic disorders and brain MRI were
unremarkable. Aminophylline was used during this period,
but with equivocal efficacy. He had delayed meconium
passage after birth, as well as persistent abdominal
distension and would only defecate after enema.
A lower gastrointestinal image was performed, revealing
a transitional zone 2e3 cm above the anus, suggestive of
Hirschsprung disease; subsequent rectal suction biopsy
proved the diagnosis. Based on the clinical features of
hypoventilation with increased ventilator support during
sleep and Hirschsprung disease, CCHS was highly suspected.
Tracheostomy and gastrostomy were performed. However,
a sudden onset of respiratory distress occurred 1 day after
surgery; the chest X-ray showed tension pneumothorax.
Despite immediate emergent treatment and resuscitation,
the patient suffered asphyxia. He developed severe hypo-
xiceischemic encephalopathy and central diabetes insidi-
pus within 2 days. After severe brain injury, bradycardia
with hypotension occurred in the following days. The family
denied further resuscitation, and the patient expired.
Genetic analysis disclosed polyanaline stretch with 20/27
repeats expansion in the PHOX2B gene (Figure 1), con-
firming the diagnosis of CCHS.3. Discussion
Patients with CCHS usually have physiologic and anatomic
manifestations of generalized autonomic system dysregu-
lation, and they may present esophageal dysmotility,
various ocular abnormalities, decreased heart rate vari-
ability, and attenuated blood pressure fluctuation.1,2,4,5
Some patients present altered development of neural
crest-derived structures. Hirschsprung disease was noted in
about 20% of CCHS cases, and ganglioneuroblastoma or
neuroblastoma was noted in approximately 5% of CCHS
cases.2,7 However, CCHS complicates 1.5% of all cases of
Hirschsprung disease, and approximately 15e20% of
patients having both CCHS and Hirschsprung disease are
diagnosed with neuroblastoma or ganglioneuroblastoma.8
More recent studies have clarified mutations of the
PHOX2B gene in at least 90% of probands with CCHS.9 The
PHOX2B gene locates on chromosome 4p12, encoding
a paired box homeodomain transcription factor and devoting
to the formation of autonomic medullary reflex pathways.10
More than 90% of cases will be heterozygous for an inframe
polyanaline expansion repeatmutation (PARM), consisting of
25e33 repeats and producing genotypes of 20/25 to 20/33,
whereas 20/20 as the normal genotype. Most PARMs occur as
de novo mutations, but 5e10% are inherited from a mosaic
typically unaffected parent. Detection of the same PHOX2B
mutation in parentechild pairs and somatic mosaicism in
unaffected parents withmutation in their affected child had
established an autosomal dominant inheritance pattern. The
genotype analysis revealed that the size of the PARM corre-
lated closely with the penetrance and the severity of the
clinical phenotype. Individuals with 20/25 genotype may
neither lead to Hirschsprung disease nor tumor formation,
70 T.-C. Wang et albut comprise the most frequent mutation of late-onset
disease; in contrast, individuals with 20/27 to 20/33 geno-
type typically require continuous ventilator support.4,9,11
The remaining 10% of CCHS patients will be heterozygous
of non-PARM, including missense, nonsense, and frame-
shift, which are almost all de novo mutations with rare
exceptions. These non-PARM CCHS usually have more
severe phenotypes. Hirschsprung disease is more prevalent
and tumors of neural crest origin are more frequent in non-
PARM individuals (50%) than in PARM ones. Although
previous reports indicate that increased size of polyanaline
repeats was associated with increased symptoms of auto-
nomic dysfunction, the risk remains unknown.10,11
Children with CCHS present more severe gas-exchange
disturbance during nonrapid eye movement period, but
most CCHS patients are capable of maintaining adequate
ventilation during wakefulness. This may suggest that the
intrinsic defect of CCHS always exists but expresses more
prominently when other redundant mechanisms are either
less active or inoperative, and may probably relate to
residual peripheral chemoreceptor function.12 Increased
mean diffusivity values in the caudate nuclei and gliosis in
the brainstem have been noted by functional magnetic
resonance imaging. However, this may be a response to
hypoxia and ischemia insult related to CCHS; the relation
between the anomaly and the disease is not clear.13
CCHS should be considered in children with episodic or
sustained hypoventilation or hypoxemia in the 1st month of
life. The diagnosis is based on detailed history-taking,
physical examination, and confirmatory molecular testing.
Tailored ventilator supportmatching the patient’s lifestyle is
the main goal of treatment. Management of related auto-
nomic dysregulation is also necessary, such as tracheostomy
for long-term mechanical ventilation, gastrostomy for
feeding difficulty, and correction of Hirschsprung disease.1,2
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